Medical Director
Maryland Treatment Centers
Johns Hopkins University School of Medicine
Baltimore, Maryland
Marc Fishman MD is a specialist in addiction psychiatry and addiction medicine. He is a member of the faculty of the Department of Psychiatry at the Johns Hopkins University School of Medicine. He leads Maryland Treatment Centers, which offers programs for residential and outpatient treatment of SUD and co-occurring disorders in adolescents, young adults, and adults. He has been a principal investigator on numerous research studies in addiction and published extensively in the field. His academic focus has been in medication treatment for OUD and other SUDs, treatment of opioid use disorder in youth, models of care and treatment engagement strategies. Dr. Fishman served as a co-editor for past editions of ASAMs Patient Placement Criteria, leading the adolescent section, and served as the chief editor for the ASAM PPC Supplement on Pharmacotherapies for Alcohol Use Disorders. He was a member of the Guideline Committee that developed the ASAM National Practice Guideline for the Treatment of OUD in 2015 and its update in 2020. He is the chair of the Adolescent SIG for ASAM. He is a Past President of the Maryland Society of Addiction Medicine, and a current memeber of its Board.
Improving Outcomes for Youth OUD Treatment
Friday, April 25, 2025
10:30 AM – 11:45 AM
Disclosure(s): Alkermes: Consultant/Advisory Board (Ongoing), Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Braeburn Pharmaceuticals: medication for research studies (Ongoing); Drug Delivery LLC: Consultant/Advisory Board (Ongoing); Indivior: Consultant/Advisory Board (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Nirsum Labs: Consultant/Advisory Board (Ongoing); USWorld Meds: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
